RADIO-PHARMACEUTICAL COMPLEXES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20220143229A1
SERIAL NO

17581808

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method for the formation of a tissue-targeting thorium complex, said method comprising;

    a) forming an octadentate chelator comprising four hydroxypyridinone (HOPO) moieties, substituted in the N-position with a methyl group, and a coupling moiety terminating in a carboxylic acid group;b) coupling said octadentate chelator to at least one tissue-targeting moiety targeting HER2; andc) contacting said tissue-targeting chelator with an aqueous solution comprising an ion of at least one alpha-emitting thorium isotope.A method of treatment of a neoplastic or hyperplastic disease comprising administration of such a tissue-targeting thorium complex, as well as the complex and corresponding pharmaceutical formulations are also provided

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTMÜLLERSTR 178 BERLIN 13353

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CUTHBERTSON, Alan Oslo, NO 103 1205
LINDEN, Lars Gevelsberg, DE 27 234

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation